Mucolife
1 known investors
MucoLife Therapeutics develops a mucus-modulating therapeutic designed to dissolve mucus obstructions in the airways of patients with chronic obstructive pulmonary disease and cystic fibrosis. The company operates in the therapeutic treatment space for respiratory diseases.
BiotechHealthtech